| Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn’s disease G Fiorino, C Bonifacio, M Padrenostro, FM Sposta, A Spinelli, A Malesci, ... Digestive diseases and sciences 58, 3246-3255, 2013 | 48 | 2013 |
| Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab C Giannitto, FM Sposta, A Repici, G Vatteroni, E Casiraghi, E Casari, ... La radiologia medica 125, 1260-1270, 2020 | 47 | 2020 |
| Bronchoalveolar lavage in suspected COVID-19 cases with a negative nasopharyngeal swab: a retrospective cross-sectional study in a high-impact Northern Italy area C Barberi, E Castelnuovo, A Dipasquale, F Mrakic Sposta, G Vatteroni, ... Internal and Emergency Medicine, 1-8, 2021 | 23 | 2021 |
| Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional … M Lazzeri, S Duga, E Azzolini, V Fasulo, N Buffi, A Saita, G Lughezzani, ... Minerva Urology and Nephrology 74 (1), 77-84, 2021 | 13 | 2021 |
| Volume-of-interest aware deep neural networks for rapid chest CT-based COVID-19 patient risk assessment A Chatzitofis, P Cancian, V Gkitsas, A Carlucci, P Stalidis, G Albanis, ... International Journal of Environmental Research and Public Health 18 (6), 2842, 2021 | 9 | 2021 |
| A prospective comparison between 1.5 T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn's disease: a single center experience G Fiorino, C Bonifacio, M Padrenostro, F Sposta, L Balzarini, A Repici, ... Gastroenterology 140 (5), S695-S695, 2011 | 5 | 2011 |
| Phase I trial of tivantinib in combination with carboplatin and pemetrexed as first-line treatment in patients with advanced nonsquamous non small cell lung cancer or malignant … PA Zucali, M Simonelli, F De Vincenzo, G Fatuzzo, M Bertossi, M Perrino, ... Journal of Clinical Oncology 33 (15_suppl), 2549-2549, 2015 | 4 | 2015 |
| A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy. M Perrino, S Bozzarelli, PA Zucali, TM De Pas, M Simonelli, ... Journal of Clinical Oncology 36 (15_suppl), 8579-8579, 2018 | 3 | 2018 |
| DOP036 Lémann Index assessment over time in Crohn's disease patients treated with anti TNFs: a pilot observational cohort study G Fiorino, M Allocca, C Bonifacio, P Naccarato, F Mrakic Sposta, ... Journal of Crohn's and Colitis 8 (Supplement_1), S32-S32, 2014 | 2 | 2014 |
| Tivantinib in combination with Carboplatin and Pemetrexed as first line treatment in patients with advanced non-squamous NSCLC or Malignant Pleural Mesothelioma: results of … PA Zucali, M Simonelli, F De Vincenzo, G Fatuzzo, M Bertossi, M Perrino, ... Annals of Oncology 26, vi78, 2015 | 1 | 2015 |
| Lémann index assessment overtime in Crohn's disease patients treated with anti TNFs: a pilot observational Cohort study G Fiorino, M Allocca, C Bonifacio, P Naccarato, F Sposta, A Spinelli, ... Gastroenterology 146 (5), S240-S240, 2014 | 1 | 2014 |
| Diagnostic Performance of Chest CT in Suspected COVID-19 Patients with a Negative First RT-PCR Testing C Giannitto, FM Sposta, A Repici, G Vatteroni, E Casiraghi, E Casari, ... Available at SSRN 3592655, 2020 | | 2020 |
| AB030. PS01. 12. A phase II study of regorafenib in patients with thymoma and thymic carcinoma previously treated with chemotherapy M Perrino, S Bozzarelli, PA Zucali, T De Pas, M Simonelli, F De Vincenzo, ... Mediastinum 1 (9), 2017 | | 2017 |
| Value of preoperative magnetic resonance enterography to predict surgical findings and to guide decisions in Crohn’s disease: a prospective study C Bonifacio, A Spinelli, G Fiorino, P Bazzi, S Danese, F Mrakic-Sposta, ... European Congress of Radiology-ECR 2013, 2013 | | 2013 |
